Tag: biomedical
-
Dual Antibodies in Trial to Prevent Covid-19 Infections
A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infections, while also in a trial as a treatment for the disease.
-
Covid-19 Vaccines, Therapies – 6 July 2020
A continuing feature on Science & Enterprise is a weekly status report of vaccines and therapies for Covid-19 by the scientific illustration software company BioRender.
-
Mobile App Screens for Sleep Apnea
A medical software team designed a mobile app that records and analyzes a person’s sounds and sleep positions to detect signs of sleep apnea.
-
Biotech IDs Potent Covid-19 Antibodies
A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections.
-
Polymer Boosts Insulin Speed, Stability
Researchers discovered a polymer compound added to insulin that in tests with pigs cuts insulin’s acting time in half and more than doubles its usable life.
-
FDA Sets Review Criteria for Covid-19 Vaccines
The Food and Drug Administration issued its standards that developers need to meet in evidence submitted for review of vaccines to prevent Covid-19 infections.
-
Glove-App System Translates Sign Language to Speech
University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech.
-
Crispr Heart Therapy Demonstrated in Monkeys
An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease.
-
Covid-19 Vaccines, Therapies – 29 June 2020
We’re following advances in Covid-19 vaccines and therapies with the help of a tracking service created by BioRender, a scientific illustration software company.
-
Trial to Test Stem Cells for Covid-19 Prevention
A company that collects and stores a person’s own stem cells for therapies later on says FDA cleared a clinical trial of donated stem cells to prevent Covid-19 infections.